DNA methylation abnormalities in atherosclerosis

References

• Hansson GK, Robertson A-K, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006;1:297–329.
   PubMed Web of Science ®Google Scholar
• Singh M, Bedi US. Is atherosclerosis regression a realistic goal of statin therapy and what does that mean? Curr Atherosc Rep. 2013;15:294.
   PubMed Web of Science ®Google Scholar
• Worthley SG, Osende JI, Helft G, et al. Coronary artery disease: pathogenesis and acute coronary syndromes. Mt Sinai J Med. 2001;68(3):167–181.
   PubMedGoogle Scholar
• Sipahi I, Tuzcu EM. Candidate mechanisms for regression of coronary atherosclerosis with high-dose statins. Am J Cardiovasc Drugs. 2008;8:365–371.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM. Inflammation and atherothrombosis: from population biology and bench research to clinical practice. J Am Coll Cardiol. 2006;48:A33–A46.
   Web of Science ®Google Scholar
• Študentová H, Indráková J, Petrová P, et al. Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor. Oncol Lett. 2016;11:939–944.
   PubMed Web of Science ®Google Scholar
• van Diepen JA, Berbée JF, Havekes LM, et al. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis. Atherosclerosis. 2013;228:306–315.
   PubMed Web of Science ®Google Scholar
• Bennett M, Wang J, Uryga AK, et al. Vascular smooth muscle cell senescence promotes atherosclerosis and features of plaque vulnerability. Circulation. 2015;132:1909–1919.
   PubMed Web of Science ®Google Scholar
• Yu X-H, Fu Y-C, Zhang D-W, et al. Foam cells in atherosclerosis. Clin Chim Acta. 2013;424:245–252.
   PubMed Web of Science ®Google Scholar
• Sanjadi M, Rezvanie Sichanie Z, Totonchi H, et al. Atherosclerosis and autoimmunity: a growing relationship. Int J Rheum Dis. 2018;21:908–921.
   PubMed Web of Science ®Google Scholar
• Zhang X, Fu R, Yu J, et al. DNA demethylation: where genetics meets epigenetics. Cpd. 2014;20:1625–1631.
   Web of Science ®Google Scholar
• Fritz EL, Papavasiliou FN. Cytidine deaminases: AIDing DNA demethylation? Genes Dev. 2010;24:2107–2114.
   PubMed Web of Science ®Google Scholar
• Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell. 2011;146:866–872.
   PubMed Web of Science ®Google Scholar
• Needham BL, Smith JA, Zhao W, et al. Life course socioeconomic status and DNA methylation in genes related to stress reactivity and inflammation: the multi-ethnic study of atherosclerosis. Epigenetics. 2015;10:958–969.
   PubMed Web of Science ®Google Scholar
• Aslani S, Mahmoudi M, Garshasbi M, et al. Evaluation of DNMT1 gene expression profile and methylation of its promoter region in patients with ankylosing spondylitis. Clin Rheumatol. 2016;35:2723–2731.
   PubMed Web of Science ®Google Scholar
• Karami J, Mahmoudi M, Amirzargar A, et al. Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients. Genes Immun. 2017;18:170.
   PubMed Web of Science ®Google Scholar
• Aslani S, Mahmoudi M, Karami J, et al. Epigenetic alterations underlying autoimmune diseases. Autoimmunity. 2016;49:69–83.
   PubMed Web of Science ®Google Scholar
• Aslani S, Jafari N, Javan MR, et al. Epigenetic modifications and therapy in multiple sclerosis. Neuromol Med. 2017;19:11–23.
   PubMed Web of Science ®Google Scholar
• Foma AM, Aslani S, Karami J, et al. Epigenetic involvement in etiopathogenesis and implications in treatment of systemic lupus erythematous. Inflamm Res. 2017;66:1057–1073.
   PubMed Web of Science ®Google Scholar
• Zaina S, Lund G. Cardiovascular epigenome-wide association studies: is epigenetics falling short? Curr Opin Lipidol. 2014;25:474–475.
   PubMed Web of Science ®Google Scholar
• Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 2010;11:204.
   PubMed Web of Science ®Google Scholar
• Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315.
   PubMed Web of Science ®Google Scholar
• Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol. 1987;196:261–282.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng C. Role of DNA methylation in cardiovascular diseases. Clin Exp Hypertension. 2016;38:261–267.
   PubMed Web of Science ®Google Scholar
• Bogdanović O, Veenstra G. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma. 2009;118:549–565.
   PubMed Web of Science ®Google Scholar
• Daniel FI, Cherubini K, Yurgel LS, et al. The role of epigenetic transcription repression and DNA methyltransferases in cancer. Cancer. 2011;117:677–687.
   PubMed Web of Science ®Google Scholar
• Roman-Gomez J, Jimenez-Velasco A, Agirre X, et al. Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene. 2005;24:7213.
   PubMed Web of Science ®Google Scholar
• Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31:27–36.
   PubMed Web of Science ®Google Scholar
• Liu M, Timmons BW. The effect of acute exercise on neutrophil reactive oxygen species production and inflammatory markers in healthy prepubertal and adult males. Pediatr Exerc Sci. 2016;28:55–63.
   PubMed Web of Science ®Google Scholar
• Kim GH, Ryan JJ, Marsboom G, et al. Epigenetic mechanisms of pulmonary hypertension. Pulm Circ. 2011;1:347–356.
   PubMedGoogle Scholar
• Kobayashi S, Inoue N, Azumi H, et al. Expressional changes of the vascular antioxidant system in atherosclerotic coronary arteries. Jat. 2002;9:184–190.
   Google Scholar
• Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem. 1997;272:20313–20316.
   PubMed Web of Science ®Google Scholar
• Finkel T, Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature. 2000;408:239.
   PubMed Web of Science ®Google Scholar
• Nanduri J, Prabhakar NR. Epigenetic regulation of carotid body oxygen sensing: clinical implications. In: Peers C, Kumar P, Wyatt C, et al., editors. Arterial chemoreceptors in physiology and pathophysiology. Switzerland: Springer International Publishing; 2015. p. 1–8.
   Google Scholar
• Lim S-O, Gu J-M, Kim MS, et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology. 2008;135:2128–2140. e8.
   PubMed Web of Science ®Google Scholar
• Niu Y, DesMarais TL, Tong Z, et al. Oxidative stress alters global histone modification and DNA methylation. Free Radic Biol Med. 2015;82:22–28.
   PubMed Web of Science ®Google Scholar
• Afanas’ev I. Mechanisms of superoxide signaling in epigenetic processes: relation to aging and cancer. A&D. 2015;6:216.
   Web of Science ®Google Scholar
• Weitzman SA, Turk PW, Milkowski DH, et al. Free radical adducts induce alterations in DNA cytosine methylation. Proc Natl Acad Sci. 1994;91:1261–1264.
   PubMed Web of Science ®Google Scholar
• Turk PW, Laayoun A, Smith SS, et al. DNA adduct 8-hydroxyl-2'-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase. Carcinogenesis 1995;16:1253–1255.
   PubMed Web of Science ®Google Scholar
• Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 2007;67:946–950.
   PubMed Web of Science ®Google Scholar
• O'Hagan HM, Wang W, Sen S, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell. 2011;20:606–619.
   PubMed Web of Science ®Google Scholar
• Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21:243.
   PubMed Web of Science ®Google Scholar
• Valko M, Rhodes C, Moncol J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1–40.
   PubMed Web of Science ®Google Scholar
• Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324:930–935.
   PubMed Web of Science ®Google Scholar
• Shpyleva S, Ivanovsky S, de Conti A, et al. Cerebellar oxidative DNA damage and altered DNA methylation in the BTBR T + tf/J mouse model of autism and similarities with human post mortem cerebellum. PloS One. 2014;9:e113712.
   PubMed Web of Science ®Google Scholar
• Wilson GA, Dhami P, Feber A, et al. Resources for methylome analysis suitable for gene knockout studies of potential epigenome modifiers. GigaScience 2012;1:3.
   PubMed Web of Science ®Google Scholar
• Morgan GT, Jones P, Bellini M. Association of modified cytosines and the methylated DNA-binding protein MeCP2 with distinctive structural domains of lampbrush chromatin. Chromosome Res. 2012;20:925–942.
   PubMed Web of Science ®Google Scholar
• Vilkaitis G, Merkiene E, Serva S, et al. The mechanism of DNA cytosine-5 methylation kinetic and mutational dissection of Hhai methyltransferase. J Biol Chem. 2001;276:20924–20934.
   PubMed Web of Science ®Google Scholar
• Griffiths EA, Gore SD. MicroRNA: mIR-ly regulators of DNMT? Blood. 2009;113:6269–6270.
   PubMed Web of Science ®Google Scholar
• Vanhoutte P, Shimokawa H, Feletou M, et al. Endothelial dysfunction and vascular disease – a 30th anniversary update. Acta Physiol (Oxf). 2017;219:22–96.
   PubMed Web of Science ®Google Scholar
• Kuvikova I, Shevchuk S. Patients with have a level of endothelin-1 an antifosfolipid syndrome: connection is with motion of disease, disfunction of endothelia and atherosclerosis. Likars' ka Sprava. 2014;12:26–33.
   Google Scholar
• Buttery L, Springall D, Chester A, et al. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77–85.
   PubMed Web of Science ®Google Scholar
• Sugiyama S, Okada Y, Sukhova GK, et al. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001;158:879–891.
   PubMed Web of Science ®Google Scholar
• Ding Z, Liu S, Wang X, et al. Hemodynamic shear stress via ROS modulates PCSK9 expression in human vascular endothelial and smooth muscle cells and along the mouse aorta. Antioxid Redox Signal. 2015;22:760–771.
   PubMed Web of Science ®Google Scholar
• Stenvinkel P, Karimi M, Johansson S, et al. Impact of inflammation on epigenetic DNA methylation–a novel risk factor for cardiovascular disease? J Intern Med. 2007;261:488–499.
   PubMed Web of Science ®Google Scholar
• Shuto T, Furuta T, Oba M, et al. Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. FASEB J. 2006;20:782–784.
   PubMed Web of Science ®Google Scholar
• Karimi M, Johansson S, Stach D, et al. LUMA (LUminometric Methylation Assay)-a high throughput method to the analysis of genomic DNA methylation . Exp Cell Res. 2006;312:1989–1995.
   PubMed Web of Science ®Google Scholar
• Ianni M, Porcellini E, Carbone I, et al. Genetic factors regulating inflammation and DNA methylation associated with prostate cancer. Prostate Cancer Prostatic Dis. 2013;16:56.
   PubMed Web of Science ®Google Scholar
• Cipollone F, Fazia ML. COX-2 and atherosclerosis. J Cardiovasc Pharmacol. 2006;47:S26–S36.
   PubMed Web of Science ®Google Scholar
• Denke MA, Grundy SM. Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med. 1990;112:780–792.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Masuda J, Imamura T, et al. A nation-wide study of atherosclerosis in infants, children and young adults in Japan. Atherosclerosis. 1988;72:143–156.
   PubMed Web of Science ®Google Scholar
• Gallotta G, Iazzetta N, Milan G, et al. Prevalence of peripheral arterial disease in an elderly rural population of southern Italy. Gerontology. 1997;43:289–295.
   PubMed Web of Science ®Google Scholar
• Holliday R. The inheritance of epigenetic defects. Science. 1987;238:163–170.
   PubMed Web of Science ®Google Scholar
• Holliday R. The significance of DNA methylation in cellular aging. In: Woodhead AD, Blackett AD, Hollaender A, editors. Molecular biology of aging. New York, NY: Springer; 1985. p. 269–283.
   Google Scholar
• Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science. 1983;220:1055–1057.
   PubMed Web of Science ®Google Scholar
• Mays-Hoopes L, Chao W, et al. Decreased methylation of the major mouse long interspersed repeated DNA during aging and in myeloma cells. Dev Genet. 1986;7:65–73.
   PubMedGoogle Scholar
• Wilson VL, Smith R, Ma S, et al. Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem. 1987;262:9948–9951.
   PubMed Web of Science ®Google Scholar
• Drinkwater RD, Blake TJ, Morley AA, et al. Human lymphocytes aged in vivo have reduced levels of methylation in transcriptionally active and inactive DNA. Mutat Res DNAging. 1989;219:29–37.
   PubMed Web of Science ®Google Scholar
• Issa J. CpG-island methylation in aging and cancer. Curr Top Microbiol Immunol. 2000;249:101–118.
   PubMed Web of Science ®Google Scholar
• Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999;43:985–991.
   PubMed Web of Science ®Google Scholar
• Ying AK, Hassanain HH, Roos CM, et al. Methylation of the estrogen receptor-α gene promoter is selectively increased in proliferating human aortic smooth muscle cells. Cardiovasc Res. 2000;46:172–179.
   PubMed Web of Science ®Google Scholar
• Laukkanen MO, Mannermaa S, Hiltunen MO, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol. 1999;19:2171–2178.
   PubMed Web of Science ®Google Scholar
• Steucke KE, Tracy PV, Hald ES, et al. Vascular smooth muscle cell functional contractility depends on extracellular mechanical properties. J Biomech. 2015;48:3044–3051.
   PubMed Web of Science ®Google Scholar
• Krychtiuk KA, Kastl SP, Hofbauer SL, et al. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein (a). J Clin Lipidol. 2015;9:533–541.
   PubMed Web of Science ®Google Scholar
• Berliner JA, Watson AD. A role for oxidized phospholipids in atherosclerosis. N Engl J Med. 2005;353:9–11.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317.
   PubMed Web of Science ®Google Scholar
• Sazonova OV, Isenberg BC, Herrmann J, et al. Extracellular matrix presentation modulates vascular smooth muscle cell mechanotransduction. Matrix Biol. 2015;41:36–43.
   PubMed Web of Science ®Google Scholar
• Choi ET, Collins ET, Marine LA, et al. Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injury-induced accelerated atherosclerotic plaque development in apolipoprotein E–deficient mice. Atvb. 2005;25:1020–1025.
   Web of Science ®Google Scholar
• Johnson JL, George SJ, Newby AC, et al. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. Proc Natl Acad Sci. 2005;102:15575–15580.
   PubMed Web of Science ®Google Scholar
• Luttun A, Lutgens E, Manderveld A, et al. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation. 2004;109:1408–1414.
   PubMed Web of Science ®Google Scholar
• Jeong J-W, Kim JW, Ku SK, et al. Essential oils purified from Schisandrae semen inhibits tumor necrosis factor-α-induced matrix metalloproteinase-9 activation and migration of human aortic smooth muscle cells. BMC Complement Altern Med. 2015;15:7.
   PubMed Web of Science ®Google Scholar
• Lacolley P, Regnault V, Nicoletti A, et al. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res. 2012;95:194–204.
   PubMed Web of Science ®Google Scholar
• Alexander MR, Owens GK. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol. 2012;74:13–40.
   PubMed Web of Science ®Google Scholar
• Spin JM, Maegdefessel L, Tsao PS. Vascular smooth muscle cell phenotypic plasticity: focus on chromatin remodelling. Cardiovasc Res. 2012;95:147–155.
   PubMed Web of Science ®Google Scholar
• de Oca AM, Madueno JA, Martinez‐Moreno JM, et al. High‐phosphate‐induced calcification is related to SM22α promoter methylation in vascular smooth muscle cells. J Bone Miner Res. 2010;25:1996–2005.
   PubMed Web of Science ®Google Scholar
• Hiltunen MO, Turunen MP, Häkkinen TP, et al. DNA hypomethylation and methyltransferase expression in atherosclerotic lesions. Vasc Med. 2002;7:5–11.
   PubMed Web of Science ®Google Scholar
• Chen K-C, Wang Y-S, Hu C-Y, et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: a novel mechanism for cardiovascular diseases. FASEB J. 2011;25:1718–1728.
   PubMed Web of Science ®Google Scholar
• Little PJ, Rostam MA, Piva TJ, et al. Suramin inhibits PDGF‐stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cells. J Pharm Pharmacol. 2013;65:1055–1063.
   PubMed Web of Science ®Google Scholar
• Couffinhal T, Duplaa C, Moreau C, et al. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res. 1994;74:225–234.
   PubMed Web of Science ®Google Scholar
• Azechi T, Sato F, Sudo R, et al. 5-Aza-2-deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells. J Atheroscler Thromb. 2014;21:463–476.
   PubMed Web of Science ®Google Scholar
• Ning Y, Huang H, Dong Y, et al. 5-Aza-2'-deoxycytidine inhibited PDGF-induced rat airway smooth muscle cell phenotypic switching. Arch Toxicol. 2013;87:871–881.
   PubMed Web of Science ®Google Scholar
• Perna AF, Ingrosso D. Atherosclerosis determinants in renal disease: how much is homocysteine involved? Nephrol Dial Transplant. 2016;31:860–863.
   PubMed Web of Science ®Google Scholar
• Mandaviya PR, Stolk L, Heil SG. Homocysteine and DNA methylation: a review of animal and human literature. Mol Genet Metab. 2014;113:243–252.
   PubMed Web of Science ®Google Scholar
• Ji C, Kaplowitz N. Hyperhomocysteinemia, endoplasmic reticulum stress, and alcoholic liver injury. Wjg. 2004;10:1699.
   PubMed Web of Science ®Google Scholar
• Kaul S, Zadeh AA, Shah PK. Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated. J Am Coll Cardiol. 2006;48:914–923.
   PubMed Web of Science ®Google Scholar
• Castro R, Rivera I, Struys EA, et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin Chem. 2003;49:1292–1296.
   PubMed Web of Science ®Google Scholar
• Yideng J, Jianzhong Z, Ying H, et al. Homocysteine-mediated expression of SAHH, DNMTs, MBD2, and DNA hypomethylation potential pathogenic mechanism in VSMCs. DNA Cell Biol. 2007;26:603–611.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Sun T, Xiong J, et al. Hyperhomocysteinemia‐mediated DNA hypomethylation and its potential epigenetic role in rats. Acta Biochim Biophys Sin. 2007;39:657–667.
   Google Scholar
• Han XB, Zhang HP, Cao CJ, et al. Aberrant DNA methylation of the PDGF gene in homocysteine-mediated VSMC proliferation and its underlying mechanism. Mol Med Rep. 2014;10:947–954.
   PubMed Web of Science ®Google Scholar
• Huang Y-S, Zhi Y-F, Wang S-R. Hypermethylation of estrogen receptor-α gene in atheromatosis patients and its correlation with homocysteine. Pathophysiology. 2009;16:259–265.
   PubMedGoogle Scholar
• Leach NV, Dronca E, Vesa SC, et al. Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis. Eur J Int Med. 2014;25:762–767.
   PubMed Web of Science ®Google Scholar
• Bao XmZheng H. Atorvastatin attenuates homocysteine‐induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK. Clin Exp Pharmacol Physiol. 2015;42:865–873.
   PubMed Web of Science ®Google Scholar
• Yideng J, Zhihong L, Jiantuan X, et al. Homocysteine-mediated PPARα, γ DNA methylation and its potential pathogenic mechanism in monocytes. DNA Cell Biol. 2008;27:143–150.
   PubMed Web of Science ®Google Scholar
• Jamaluddin MS, Yang X, Wang H. Hyperhomocysteinemia, DNA methylation and vascular disease. Clinical Chemical Laboratory Medicine 2007;45:1660–1666.
   PubMed Web of Science ®Google Scholar
• Yi-Deng J, Tao S, Hui-Ping Z, et al. Folate and ApoE DNA methylation induced by homocysteine in human monocytes. DNA Cell Biol. 2007;26:737–744.
   PubMed Web of Science ®Google Scholar
• Wang J, Yu L, Zheng X. PTPα-mediated Src activation by EGF in human breast cancer cells. Acta Biochim Biophys Sin (Shanghai). 2013;45:320–329.
   PubMed Web of Science ®Google Scholar
• Yang X, Li Y, Li Y, et al. Oxidative stress-mediated atherosclerosis: mechanisms and therapies. Front Physiol. 2017;8:600.
   PubMed Web of Science ®Google Scholar
• Cao Q, Wang X, Jia L, et al. Inhibiting DNA methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation. Endocrinology. 2014;155:4925–4938.
   PubMed Web of Science ®Google Scholar
• Rasmussen MA, Holst B, Tümer Z, et al. Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage. Stem Cell Rep. 2014;3:404–413.
   PubMed Web of Science ®Google Scholar
• Ma S, Zhang H, Sun W, et al. Hyperhomocysteinemia induces cardiac injury by up-regulation of p53-dependent Noxa and Bax expression through the p53 DNA methylation in ApoE−/− mice. Acta Biochim Biophys Sin. 2013;45:391–400.
   Google Scholar
• Hara S, Takano T, Fujikawa T, et al. Forced expression of DNA methyltransferases during oocyte growth accelerates the establishment of methylation imprints but not functional genomic imprinting. Human Mol Genet. 2014;23:3853–3864.
   PubMed Web of Science ®Google Scholar
• Wang T, Chen M, Liu L, et al. Nicotine induced CpG methylation of Pax6 binding motif in StAR promoter reduces the gene expression and cortisol production. Toxicol Appl Pharmacol. 2011;257:328–337.
   PubMed Web of Science ®Google Scholar
• Canani RB, Paparo L, Nocerino R, et al. Differences in DNA methylation profile of Th1 and Th2 cytokine genes are associated with tolerance acquisition in children with IgE-mediated cow’s milk allergy. Clin Epigenet. 2015;7:38.
   PubMed Web of Science ®Google Scholar
• Joyce BT, Gao T, Liu L, et al. Longitudinal study of DNA methylation of inflammatory genes and cancer risk. Cancer Epidemiol Prevent Biomarkers 2015;24:1531–1538.
   PubMed Web of Science ®Google Scholar
• Deaton AM, Cook PC, De Sousa D, et al. A unique DNA methylation signature defines a population of IFN‐γ/IL‐4 double‐positive T cells during helminth infection. Eur J Immunol. 2014;44:1835–1841.
   PubMed Web of Science ®Google Scholar
• Wierda RJ, Kuipers HF, van Eggermond MC, et al. Epigenetic control of CCR5 transcript levels in immune cells and modulation by small molecules inhibitors. J Cell Mol Med. 2012;16:1866–1877.
   PubMed Web of Science ®Google Scholar
• Kennedy A, Schmidt EM, Cribbs AP, et al. A novel upstream enhancer of FOXP3, sensitive to methylation‐induced silencing, exhibits dysregulated methylation in rheumatoid arthritis Treg cells. Eur J Immunol. 2014;44:2968–2978.
   PubMed Web of Science ®Google Scholar
• Kim D, Kubzansky LD, Baccarelli A, et al. Psychological factors and DNA methylation of genes related to immune/inflammatory system markers: the VA Normative Aging Study. BMJ Open. 2016;6:e009790.
   PubMed Web of Science ®Google Scholar
• Liu C, Xu D, Sjöberg J, et al. Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res. 2004;297:61–67.
   PubMed Web of Science ®Google Scholar
• Hastings NE, Simmers MB, McDonald OG, et al. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol. 2007;293:C1824–C33.
   PubMed Web of Science ®Google Scholar
• Laukkanen MO, Mannermaa S, Hiltunen MO, et al. Local hypomethylation in atherosclerosis found in rabbit ec-sod gene. Arterioscler Thromb Vasc Biol. 1999;19:2171–2178.
   PubMed Web of Science ®Google Scholar
• Baccarelli A, Bollati V. Epigenetics and environmental chemicals. Curr Opin Pediatr. 2009;21:243.
   PubMed Web of Science ®Google Scholar
• Carless MA, Kulkarni H, Kos MZ, et al. Genetic effects on DNA methylation and its potential relevance for obesity in Mexican Americans. PLoS One 2013;8:e73950.
   PubMed Web of Science ®Google Scholar
• Chan Y, Fish JE, D'Abreo C, et al. The cell-specific expression of endothelial nitric oxide synthase: a role for DNA methylation. J Biol Chem. 2004;279:35087–35100.
   PubMed Web of Science ®Google Scholar
• Ning Y, Huang H, Dong Y, et al. 5-Aza-2′-deoxycytidine inhibited PDGF-induced rat airway smooth muscle cell phenotypic switching. Arch Toxicol. 2013;87:871–881.
   PubMed Web of Science ®Google Scholar
• Park J, Jang KL. Hepatitis C virus represses E-cadherin expression via DNA methylation to induce epithelial to mesenchymal transition in human hepatocytes. Biochem Biophys Res Commun. 2014;446:561–567.
   PubMed Web of Science ®Google Scholar
• Liu W-b, Cui Z-h, Ao L, et al. Aberrant methylation accounts for cell adhesion-related gene silencing during 3-methylcholanthrene and diethylnitrosamine induced multistep rat lung carcinogenesis associated with overexpression of DNA methyltransferases 1 and 3a. Toxicol Appl Pharmacol. 2011;251:70–78.
   PubMed Web of Science ®Google Scholar